Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City: Paris
State: Ile-de-France
Zip:
Country: France
Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations, focused on the development of transformative therapies for the treatment of worsening and acute decompensated heart failure.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2021 | Seed Round | $0 |
Invivo Capital Partners Kurma Partners Omnes Capital V-Bio Ventures Invivo Capital Partners Kurma Partners Omnes Capital V-Bio Ventures |
12/2021 | Seed Round | 4 | $13.6M |
Invivo Capital Partners Kurma Partners Omnes Capital V-Bio Ventures Invivo Capital Partners Kurma Partners Omnes Capital V-Bio Ventures |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|